← Browse by Condition
Medical Condition

multi drug resistant nephrotic syndrome

Total Trials
4
Recruiting Now
4
Trial Phases
EARLY_Phase 1, Phase 1

ClinicalMetric tracks all active clinical trials for multi drug resistant nephrotic syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
4
Top Sponsors
The Children's Hospital of Zhejiang University School of Medicine 4 trials
NCT06792799 EARLY_Phase 1
Recruiting

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Enrollment
36 pts
Location
China
Sponsor
The Children's Hospital of Zhe...
View Trial →
NCT06553898 Phase 1
Recruiting

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

Enrollment
18 pts
Location
China
Sponsor
The Children's Hospital of Zhe...
View Trial →
NCT06842589 Phase 1
Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

Enrollment
18 pts
Location
China
Sponsor
The Children's Hospital of Zhe...
View Trial →
NCT07507201 EARLY_Phase 1
Recruiting

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Enrollment
15 pts
Location
China
Sponsor
The Children's Hospital of Zhe...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology